Monetta Financial Services’s Edwards Lifesciences EW Stock Holding History

Monetta Financial Services’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-66,000	Closed	-$2.65M	–	65
2016 Q3	$2.65M	Hold	66,000	–	–	1.7%	17
2016 Q2	$2.19M	Hold	66,000	–	–	1.39%	19
2016 Q1	$1.94M	Hold	66,000	–	–	1.2%	29
2015 Q4	$1.74M	Buy	66,000 +39,000	+144%	+$1.01M	1.02%	28
2015 Q3	$640K	Hold	27,000	–	–	0.39%	54
2015 Q2	$641K	Hold	27,000	–	–	0.36%	49
2015 Q1	$641K	Buy	+27,000	New	+$606K	0.34%	54

Other funds holding EW

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Monetta Financial Services's EW Position: Q4 2016 in Review

Monetta Financial Services sold out of Edwards Lifesciences (EW) in Q4 2016, closing a stake of 66,000 shares — an estimated $2.65M sold.

Monetta Financial Services first reported a position in EW in Q1 2015 and held it in 7 quarters. The position peaked at $2.65M in Q3 2016. 686 funds tracked by Wall St. Rank hold EW as of Q4 2016.

Monetta Financial Services reported no remaining Edwards Lifesciences position as of Q4 2016 after selling out during the quarter.
Monetta Financial Services sold 66,000 Edwards Lifesciences shares in Q4 2016, an estimated $2.65M.
Monetta Financial Services first reported a position in Edwards Lifesciences in Q1 2015 and held it in 7 quarters.
Monetta Financial Services's Edwards Lifesciences position peaked at $2.65M in Q3 2016.
686 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q4 2016.

Based on Monetta Financial Services's 13F filing for Q4 2016, filed 25 Jan 2017.